LPL Financial’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.6M Buy
5,500
+5,200
+1,733% +$5.31M ﹤0.01% 2540
2026
Q1
$276K Hold
300
﹤0.01% 5244
2025
Q4
$322K Sell
300
-500
-63% -$478K ﹤0.01% 5091
2025
Q3
$610K Buy
800
+400
+100% +$298K ﹤0.01% 4460
2025
Q2
$312K Buy
+400
New +$311K ﹤0.01% 4745
2024
Q4
Sell
-500
Closed -$443K 5379
2024
Q3
$443K Sell
500
-300
-38% -$270K ﹤0.01% 4105
2024
Q2
$724K Buy
+800
New +$640K ﹤0.01% 3546

Other funds holding LLY

LPL Financial's LLY Position: Q2 2026 in Review

LPL Financial increased its Eli Lilly (LLY) stake by 6.5% in Q2 2026, buying an estimated $79.8M and bringing the position to 1,274,807 shares worth $1.53B. The position accounts for 0.34% of the portfolio, ranked #52.

LPL Financial first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 4,627 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • LPL Financial held 1,274,807 shares of Eli Lilly worth $1.53B as of Q2 2026.
  • LPL Financial bought 78,111 Eli Lilly shares in Q2 2026, an estimated $79.8M.
  • Eli Lilly made up 0.34% of LPL Financial's portfolio in Q2 2026, its #52 holding.
  • LPL Financial first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 4,627 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on LPL Financial's 13F filing for Q2 2026, filed 7 Aug 2026.